1. Home
  2. LMAT vs AZTA Comparison

LMAT vs AZTA Comparison

Compare LMAT & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LMAT
  • AZTA
  • Stock Information
  • Founded
  • LMAT 1983
  • AZTA 1978
  • Country
  • LMAT United States
  • AZTA United States
  • Employees
  • LMAT N/A
  • AZTA N/A
  • Industry
  • LMAT Medical/Dental Instruments
  • AZTA Industrial Machinery/Components
  • Sector
  • LMAT Health Care
  • AZTA Technology
  • Exchange
  • LMAT Nasdaq
  • AZTA Nasdaq
  • Market Cap
  • LMAT 1.9B
  • AZTA 1.8B
  • IPO Year
  • LMAT 2006
  • AZTA 1995
  • Fundamental
  • Price
  • LMAT $80.40
  • AZTA $26.48
  • Analyst Decision
  • LMAT Buy
  • AZTA Buy
  • Analyst Count
  • LMAT 7
  • AZTA 3
  • Target Price
  • LMAT $100.67
  • AZTA $50.67
  • AVG Volume (30 Days)
  • LMAT 225.6K
  • AZTA 1.1M
  • Earning Date
  • LMAT 05-01-2025
  • AZTA 05-07-2025
  • Dividend Yield
  • LMAT 1.00%
  • AZTA N/A
  • EPS Growth
  • LMAT 30.45
  • AZTA N/A
  • EPS
  • LMAT 1.97
  • AZTA N/A
  • Revenue
  • LMAT $226,256,000.00
  • AZTA $669,171,000.00
  • Revenue This Year
  • LMAT $13.58
  • AZTA N/A
  • Revenue Next Year
  • LMAT $8.81
  • AZTA $4.89
  • P/E Ratio
  • LMAT $40.64
  • AZTA N/A
  • Revenue Growth
  • LMAT 13.19
  • AZTA 8.56
  • 52 Week Low
  • LMAT $71.42
  • AZTA $23.91
  • 52 Week High
  • LMAT $109.58
  • AZTA $63.58
  • Technical
  • Relative Strength Index (RSI)
  • LMAT 43.38
  • AZTA 42.78
  • Support Level
  • LMAT $80.54
  • AZTA $26.96
  • Resistance Level
  • LMAT $82.78
  • AZTA $28.32
  • Average True Range (ATR)
  • LMAT 2.36
  • AZTA 1.03
  • MACD
  • LMAT -0.12
  • AZTA 0.11
  • Stochastic Oscillator
  • LMAT 25.88
  • AZTA 0.00

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

About AZTA Azenta Inc.

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.

Share on Social Networks: